On February 22nd the Food and Drug Administration (FDA) approved a generic version of GlaxoSmithKleine’s brand name drug Flonase - Fluticasone Propionate Nasal Spray. The drug patent of Flonase expired in May 2004 and the new dosing schedule exclusivity on November 23, 2005.